Maximizing productivity in R&D

The R&D organization was suffering the impact of significant failure in productivity. The challenge was to increase the delivery of meaningful medicines to the global market, in the face of industry demands due to increasing generics, increasing legislative hurdles (especially in the US and EU) and shortening patent times.

download ›
‹ back